GENE ONLINE|News &
Opinion
Blog

mRNA Technology
Special mRNA
Moving Beyond COVID With mRNA Technology
2023-01-18
Trials & Approvals Moderna
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
Partnerships Keytruda
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
Funding mRNA Technology
Singapore’s RVAC Medicines Raises $140 Million for mRNA Ambitions
2022-04-28
Asia-Pacific Moderna
Moderna Announces Plan to Set Up Subsidiaries in APAC to Provide mRNA Technology Service
2022-02-16
Special Best of 2021
GeneOnline’s Pick: Novel Biotechnologies that Made a Splash in 2021
2022-01-27
COVID-19 Vaccine
Arcturus’ COVID Vaccine Moves to Phase 2 Trial in Singapore
2021-01-05
LATEST
Healthcare+ Expo Taiwan 2024 To Become A Global Trade Fair With 600+ Companies Attending
2024-11-29
Cracking the Code: How Genetics Shapes Strength, Power, and Speed in Sports
2024-11-27
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
MIRDC Hosts Seminar Featuring Diverse Applications of Plasma Sterilization Technology
2024-11-26
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
READ MORE
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top